Disruptive MedTech Innovation: The New Era of Breast Imaging Technology with David Georges

In this episode of the Healthy Enterprise podcast, David Georges, North American president of Koning Health, discusses his extensive experience in the breast imaging industry and the innovative BreastCT technology. He shares insights into the challenges of traditional mammography, the importance of early detection, and the potential of BreastCT to revolutionize breast cancer screening. The conversation also touches on the integration of AI, the global market expansion of the technology, and the significance of mentorship and leadership in driving change within healthcare.

Chapters:
00:00 Introduction to Breast Imaging Innovations

02:49 David Georges' Journey in Breast Cancer Detection

06:02 The Evolution of Breast Imaging Technology

08:54 Challenges in Mammography and Patient Compliance

11:58 Commercialization of BreastCT Technology

14:46 Navigating Change in Medical Imaging

18:11 Global Expansion and Future Vision for Koning Health

20:45 The Impact of BreastCT on Patient Experience

23:51 Addressing Resistance and Building Trust in New Technology

26:58 The Future of Breast Imaging and Biopsy Procedures

30:33 Understanding the Breast Imaging Industry

32:28 The Role of AI in Breast Imaging

34:04 Creating Commercial Viability for New Technology

36:30 Educating Radiologists on New Imaging Techniques

39:18 Building Confidence in Radiologists

42:10 Transitioning to New Technologies in Imaging

44:57 Career Guidance in Healthcare and Technology

49:42 Mobile Breast Imaging Solutions

54:08 The Economic Impact of Early Detection

56:34 Future Prospects for Breast Imaging Technology

Guest Information:

• Guest's Name: David Georges
• Guest's Title/Position: North American President
• Guest's Linkedin: https://www.linkedin.com/in/david-georges-48a14020/
• Company / Affiliation: Koning Health https://www.koninghealth.com/
• Guest's Bio: David Georges has been a global business leader in Breast Imaging for the past twenty-five years, contributing to the introduction and substantial market growth of innovative products dedicated to the early detection of breast cancer including mammography, breast biopsy, computer aided detection, breast ultrasound and automated breast ultrasound. David has established manufacturing sites, supported luminary sites for new product introduction, and established physician and technologist training centers. He has held senior executive positions in companies such as Transworld, Lorad, Hologic, R2, SuperSonic Imagine, iVu and U-systems; the latter of which was purchased by GE.

  Since joining Koning, David has led the effort to move the company from a Research and Development group to one that is prepared for commercializing Koning’s KBCT. David’s industry relationships have introduced opportunities to establish critically important luminary partners. With a knowledge of global distribution, David has expanded the Koning installation base to Thailand, Qatar, and Netherlands.

Takeaways:

• David Georges has 40 years of experience in breast imaging.
• BreastCT technology offers true isotropic 3D imaging without compression.
• Early detection of breast cancer significantly improves treatment outcomes.
• Patient compliance with mammograms is low due to discomfort.
• Koning Health aims to integrate BreastCT into existing facilities easily.
• The technology is gaining traction in global markets, including China and Australia.
• AI will play a crucial role in interpreting BreastCT images.
• Mobile BreastCT units are being deployed to increase accessibility.
• Healthcare economics favor early detection to reduce treatment costs.